Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Crescent Biopharma, Inc.

NASDAQ: CBIO · Life Sciences · 8 alerts · CIK 1253689

Share price
$13.50Close, Nov 16
Market cap
$525M
Shares outstanding
38.9MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Crescent Biopharma, Inc. filings on SEC EDGAR ↗

4:26 PM ET 8-K
Business Update

Crescent Biopharma Business Update

Crescent Biopharma provided a comprehensive clinical pipeline update, including the commencement of chemotherapy combination cohorts in its Phase 1/2 ASCEND trial for CR-001. The company also announced the initiation of combination studies with Kelun-Biotech and set expectations for initial monotherapy data readouts in Q1 2027.

Counterparty
Kelun-Biotech Biopharmaceutical Co., Ltd.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.